Skip to main content

Advertisement

Log in

The effects of artemether–lumefantrine vs amodiaquine–sulfalene–pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

An open randomized controlled study of artemether–lumefantrine (AL) and amodiaquine–sulfalene–pyrimethamine (ASP) for the treatment of uncomplicated Plasmodium falciparum malaria was carried out in 181 children. In 79 children, the hepatomegaly reduction ratios (HRR) and the speed of resolution of hepatomegaly, the hepatomegaly resolution rates (HRSR), were calculated and compared between the two treatment groups. HRR and HRSR were similar in the two treatment groups. HRSR was 71% and 62% in AL- and ASP-treated children, respectively, 14 days after commencing treatment. There was no significant correlation between HRR and parasite reduction ratio in the same patient. In children in whom parasitaemia cleared and hepatomegaly resolved within 14 days, recurrence of parasitaemia was associated with reoccurrence of hepatomegaly, suggesting that the propensity for recurrence of infection drives the malaria-attributable hepatomegaly in children from this endemic area. Combination therapy may provide additional beneficial effects on pathophysiological processes and changes associated with falciparum malaria by rapid clearing of asexual parasitaemia and reducing the propensity for recurrence of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui P-B, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WRJ (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359:1365–1372

    Article  PubMed  Google Scholar 

  • Anonymous (1994) Epi Info Version 6. A word processing data base and statistics program for public health on IBM-compatible microcomputers. Centers for Disease Control and Prevention, Atlanta, GA

  • Anonymous (1999). SPSS for Windows release 10.01 (standard version). SPSS Inc., Chicago, IL

  • Ezzet F, van Vugt M, Nosten F, Looaresuwan S, White NJ (2000) Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 44:697–704

    Article  PubMed  CAS  Google Scholar 

  • Hien TT, White NJ (1993) Qinghaosu. Lancet 341:603–608

    Article  PubMed  CAS  Google Scholar 

  • Newton CRJC, Peshu N, Kendall B, Kirkham FJ, Sowunmi A, Waruiru C, Mwangi I, Murphy S, Marsh K (1994) Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child 70:281–287

    PubMed  CAS  Google Scholar 

  • Ngouesse B, Basco LK, Ringwald P, Keundjian A, Blackett KG (2001) Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. Am J Trop Med Hyg 65:711–716

    PubMed  CAS  Google Scholar 

  • Price RN, Nosten F, Luxemburger C, ter Kuile F, Phaipun L, Chongsuphajaisiddhi T, White NJ (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654–1658

    Article  PubMed  CAS  Google Scholar 

  • Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White NJ (1998) Artesunate versus artemether for the treatment of recrudescent multi-drug resistant falciparum malaria. Am J Trop Med Hyg 59:883–888

    PubMed  CAS  Google Scholar 

  • Salako LA, Ajayi FO, Sowunmi A, Walker O (1990) Malaria in Nigeria: a revisit. Ann Trop Med Parasitol 84:435–445

    PubMed  CAS  Google Scholar 

  • Sowunmi A (1996a) Hepatomegaly in acute falciparum malaria in children. Trans R Soc Trop Med Hyg 90:540–542

    Article  PubMed  CAS  Google Scholar 

  • Sowunmi A (1996b) Renal function in acute falciparum malaria. Arch Dis Child 74:293–298

    Article  PubMed  CAS  Google Scholar 

  • Sowunmi A, Adedeji AA (2002) The effects of chloroquine, amodiaquine and chloroquine plus chlorpheniramine on the disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children. Ann Trop Med Parasitol 96:543–551

    Article  PubMed  CAS  Google Scholar 

  • Sowunmi A, Adedeji AA, Sowunmi CO, Falade CO, Falade AG, Ohaeri B, Happi TC, Oduola AMJ (2001) Clinical characteristics and disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children. Ann Trop Med Parasitol 95:7–18

    Article  PubMed  CAS  Google Scholar 

  • Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, Happi TC, Oduola AMJ (2005) Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Trop Med Int Health 10:1161–1170

    Article  PubMed  CAS  Google Scholar 

  • Suputtamongkol Y, Chindarat S, Silpasakorn S, Chaikachonpatd S, Lim K, Chanthapakajee K, Kaewkaukul N, Thamlikitkul V (2003) The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg 68:620–623

    PubMed  CAS  Google Scholar 

  • Walters JH, Mcgregor IA (1960) The mechanism of malarial hepatomegaly. Tran R Soc Trop Med Hyg 54:135–142

    Article  CAS  Google Scholar 

  • White NJ (1986) Malaria: pathophysiology. Clin Trop Med Commun Dis 1:55–89

    Google Scholar 

  • White NJ (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41:1413–1422

    PubMed  CAS  Google Scholar 

  • White N (1999) Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B 354:739–749

    Article  CAS  Google Scholar 

  • White NJ, Ho M (1992) Pathophysiology of malaria. Adv Parasitol 33:84–175

    Google Scholar 

  • World Health Organization (1973) Chemotherapy of malaria and resistance to antimalarials. Technical report series no. 529. WHO, Geneva

  • World Health Organization (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1):1–90

    Article  Google Scholar 

  • World Health Organization (2001) Antimalarial drug combination therapy. Report of a WHO Technical Consultation (WHO/CDS/RBM/2001.35). WHO, Geneva

  • World Health Organization (2003) Assessment and monitoring of antimalarial. Drug efficacy for the treatment of uncomplicated falciparum malaria (WHO/HTM/RBM/2003.50). WHO, Geneva

Download references

Acknowledgements

The study received financial support from Pfizer Global Pharmaceuticals. We thank Drs. Chris Migom and Segun Dogunro for their support, and our clinic staff, in particular, Moji Amoo and Adeola Alabi, for assistance with running the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Sowunmi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sowunmi, A., Gbotosho, G.O., Adedeji, A.A. et al. The effects of artemether–lumefantrine vs amodiaquine–sulfalene–pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children. Parasitol Res 100, 511–517 (2007). https://doi.org/10.1007/s00436-006-0293-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-006-0293-x

Keywords

Navigation